Soc. Generale Call 90 ABT 21.03.2.../ DE000SU0P6P2 /
6/13/2024 1:06:41 PM | Chg.-0.070 | Bid1:21:40 PM | Ask1:21:40 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.750EUR | -3.85% | 1.760 Bid Size: 6,000 |
1.830 Ask Size: 6,000 |
Abbott Laboratories | 90.00 USD | 3/21/2025 | Call |
GlobeNewswire
6/6
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors